Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. CLPT
stocks logo

CLPT

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
10.05M
+29.33%
-0.200
-0%
12.20M
+43.78%
-0.205
-6.82%
13.40M
+45.42%
-0.185
-11.9%
Estimates Revision
The market is revising Downward the revenue expectations for ClearPoint Neuro, Inc. (CLPT) for FY2025, with the revenue forecasts being adjusted by -2.79% over the past three months. During the same period, the stock price has changed by 27.24%.
Revenue Estimates for FY2025
Revise Downward
down Image
-2.79%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+3.11%
In Past 3 Month
Stock Price
Go Up
up Image
+27.24%
In Past 3 Month
Wall Street analysts forecast CLPT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CLPT is 29.00 USD with a low forecast of 28.00 USD and a high forecast of 30.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
Wall Street analysts forecast CLPT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CLPT is 29.00 USD with a low forecast of 28.00 USD and a high forecast of 30.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 14.060
sliders
Low
28.00
Averages
29.00
High
30.00
Current: 14.060
sliders
Low
28.00
Averages
29.00
High
30.00
B. Riley
Buy
maintain
$20 -> $28
2025-04-25
Reason
B. Riley
Price Target
$20 -> $28
2025-04-25
maintain
Buy
Reason
B. Riley raised the firm's price target on ClearPoint Neuro to $28 from $20 and keeps a Buy rating on the shares following a transfer of coverage. ClearPoint is a medical device company focused on providing image-guided navigation for minimally invasive neuro procedures, the analyst tells investors in a research note. The firm says the company's core business continues to grow over 20% annually, and that it expects significant growth in the future as biopharma partnerships progress towards regulatory approvals and commercial launches.
Stifel
Mathew Blackman
Strong Buy
Maintains
$19 → $25
2025-04-01
Reason
Stifel
Mathew Blackman
Price Target
$19 → $25
2025-04-01
Maintains
Strong Buy
Reason
B. Riley Securities
Neil Chatterji
Strong Buy
Maintains
$15 → $20
2025-01-28
Reason
B. Riley Securities
Neil Chatterji
Price Target
$15 → $20
2025-01-28
Maintains
Strong Buy
Reason
Lake Street
Frank Takkinen
Strong Buy
Maintains
$17 → $30
2025-01-21
Reason
Lake Street
Frank Takkinen
Price Target
$17 → $30
2025-01-21
Maintains
Strong Buy
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for Clearpoint Neuro Inc (CLPT.O) is -16.94, compared to its 5-year average forward P/E of -17.83. For a more detailed relative valuation and DCF analysis to assess Clearpoint Neuro Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-17.83
Current PE
-16.94
Overvalued PE
-8.61
Undervalued PE
-27.05

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-23.86
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
-10.66
Undervalued EV/EBITDA
-37.07

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
11.38
Current PS
0.00
Overvalued PS
17.45
Undervalued PS
5.31
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

CLPT News & Events

Events Timeline

(ET)
2025-11-06
17:42:30
ClearPoint Neuro Purchases Irras Holdings; Financial Details Not Revealed
select
2025-09-04 (ET)
2025-09-04
16:37:50
ClearPoint Neuro Receives Approval for Prism Neuro Laser Therapy with 1.5T MRI Guidance
select
2025-06-03 (ET)
2025-06-03
08:54:13
Lake Street says AMT-130 could be 'significantly impactful' for ClearPoint
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
9.5
11-07SeekingAlpha
ClearPoint Neuro, Inc. Reports GAAP EPS of -$0.21, Falling Short by $0.01; Revenue of $8.86M Misses Expectations by $0.74M

  • Q3 Financial Performance: ClearPoint Neuro, Inc. reported a Q3 GAAP EPS of -$0.21, missing expectations by $0.01, with revenue of $8.86 million, which is a 9.1% year-over-year increase but also fell short by $0.74 million.

  • Full-Year Guidance: The company reaffirmed its full-year revenue guidance, narrowing the expected range to between $36.0 million and $38.0 million.

  • Future Revenue Projections: Management forecasts that the combined revenue for ClearPoint Neuro and IRRAS in 2026 is expected to be between $54.0 million and $60.0 million.

  • Strategic Initiatives: ClearPoint Neuro is advancing its global expansion plans and regulatory milestones while focusing on cell and gene therapy initiatives.

[object Object]
Preview
2.0
11-03Benzinga
Major Stocks, Including Kimberly-Clark and Vertex, Decline in Monday's Pre-Market Trading

  • U.S. Stock Futures: U.S. stock futures showed mixed results, with Nasdaq futures rising over 100 points on Monday.

  • Kimberly-Clark Acquisition: Kimberly-Clark Corporation's shares fell 13.6% in pre-market trading after announcing its acquisition of Kenvue for approximately $48.7 billion.

  • Significant Stock Declines: Several companies experienced sharp declines in pre-market trading, including uniQure N.V. (-65.3%) and ClearPoint Neuro, Inc. (-40.5%).

  • Analyst Upgrades and Downgrades: Replimune Group, Inc. saw a 16.7% dip despite an upgrade from Underperform to Market Perform by BMO Capital, while Vertex, Inc. lowered its FY2025 sales guidance, leading to a 6.1% decline.

[object Object]
Preview
4.5
10-03TipRanks
Friday's Major Stock Market Highlights: Morning News Summary!

  • Market Overview: The trading week is nearing its end, with investors engaged in significant stock market stories.

  • Resource for Investors: TipRanks has curated a list of the most notable stock market stories for Friday.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Clearpoint Neuro Inc (CLPT) stock price today?

The current price of CLPT is 14.06 USD — it has decreased -0.14 % in the last trading day.

arrow icon

What is Clearpoint Neuro Inc (CLPT)'s business?

ClearPoint Neuro, Inc. is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. It provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. Its flagship product is the ClearPoint Neuro Navigation System. It is engaged with healthcare and research centers in North America, Europe, Asia, and South America. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance. It provides solutions for direct CNS delivery of therapeutics in preclinical studies and clinical trials worldwide. It also offers IRRAflow active fluid-exchange system.

arrow icon

What is the price predicton of CLPT Stock?

Wall Street analysts forecast CLPT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CLPT is 29.00 USD with a low forecast of 28.00 USD and a high forecast of 30.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Clearpoint Neuro Inc (CLPT)'s revenue for the last quarter?

Clearpoint Neuro Inc revenue for the last quarter amounts to 8.86M USD, increased 9.10 % YoY.

arrow icon

What is Clearpoint Neuro Inc (CLPT)'s earnings per share (EPS) for the last quarter?

Clearpoint Neuro Inc. EPS for the last quarter amounts to -0.21 USD, increased 16.67 % YoY.

arrow icon

What changes have occurred in the market's expectations for Clearpoint Neuro Inc (CLPT)'s fundamentals?

The market is revising Downward the revenue expectations for ClearPoint Neuro, Inc. (CLPT) for FY2025, with the revenue forecasts being adjusted by -2.79% over the past three months. During the same period, the stock price has changed by 27.24%.
arrow icon

How many employees does Clearpoint Neuro Inc (CLPT). have?

Clearpoint Neuro Inc (CLPT) has 115 emplpoyees as of December 05 2025.

arrow icon

What is Clearpoint Neuro Inc (CLPT) market cap?

Today CLPT has the market capitalization of 418.26M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free